Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor–Based Regimen: The “STORE” Study

OBJECTIVE: This study investigates the effectiveness and tolerability of switching to a darunavir/cobicistat (DRV/c)-based antiretroviral regimen from a ritonavir-boosted protease inhibitor (PI/r)-based regimen in virologically suppressed HIV-positive patients. DRV trough values were also investigat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Acquir Immune Defic Syndr
Hauptverfasser: Gori, Andrea, Antinori, Andrea, Vergori, Alessandra, Cossu, Maria Vittoria, Menzaghi, Barbara, Sterrantino, Gaetana, Rusconi, Stefano, Cattelan, Anna Maria, Castelli, Francesco, Gianotti, Nicola, Orofino, Giancarlo, Ripamonti, Diego, Savinelli, Stefano, Manzillo, Elio, Santantonio, Teresa Antonia, Celesia, Benedetto Maurizio, Cauda, Roberto, Maserati, Renato, d'Arminio Monforte, Antonella, Stingone, Christof, Bonora, Stefano, Uglietti, Alessia, Termini, Roberta, Rucci, Francesco, Mancusi, Daniela
Format: Artigo
Sprache:Inglês
Veröffentlicht: JAIDS Journal of Acquired Immune Deficiency Syndromes 2020
Schlagworte:
Clinical Science
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7289135/
https://ncbi.nlm.nih.gov/pubmed/32101882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000002331
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge